Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.

Saved in:
Bibliographic Details
Title: Renal Outcomes in People With HIV-1 and Renal Impairment Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide: Integrated Analysis From 9 Phase 3/3b Clinical Trials.
Authors: Post, Frank A1 (AUTHOR), Wohl, David2 (AUTHOR), Liegeon, Geoffroy3 (AUTHOR), Brar, Indira4 (AUTHOR), Hagins, Debbie5 (AUTHOR), Yazdanpanah, Yazdan6 (AUTHOR), Avihingsanon, Anchalee7 (AUTHOR), Liu, Hui8 (AUTHOR), Aizen, Keith8 (AUTHOR), Hindman, Jason T8 (AUTHOR)
Source: Open Forum Infectious Diseases. May2026, Vol. 13 Issue 5, p1-4. 4p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofag265